(Amoxicillin) 500mg capsules
Lagos, Feb. 9, 2026. ONN….
The National Agency for Food and Drug Administration and Control (NAFDAC) has dismissed claims circulating on social media that it has banned the sale and use of Amoxicillin in Nigeria.
The agency described the allegation, contained in a viral video, as false and misleading.
In a statement issued on Monday, the Director-General of NAFDAC, Prof. Mojisola Adeyeye, clarified that there has been no secret or public ban on Amoxicillin in the country.
She explained that as Nigeria’s drug regulatory authority, NAFDAC communicates all regulatory decisions transparently through official and publicly accessible channels.
“NAFDAC notifies the public of regulatory actions through its recalls, safety alerts, blacklists and other official notices,” Adeyeye said.
According to her, such safety communications clearly specify affected product names, batch numbers, manufacturers and the regulatory measures required.
“These notices provide vital information that may influence treatment decisions by healthcare professionals and patients,” she added.
Adeyeye further explained that blacklisting, when applied, targets specific companies or products found to be unsafe, substandard or in violation of regulatory standards, and does not imply a blanket ban on a medicine.
She noted that in recent months, NAFDAC issued targeted safety alerts concerning certain brands and batches of Amoxicillin due to quality concerns.
“In August 2025, Public Alert No. 24/2025 announced the recall of Amoxivue (Amoxicillin) 500mg capsules following the detection of low Active Pharmaceutical Ingredient (API) content,” she said.
She added that in October 2025, the agency also issued alerts on substandard batches of Astamocil and Astamentin suspensions, while Public Alert No. 35/2025 addressed quality issues related to Annmox and Jawamox suspensions.
Adeyeye stressed that these actions were limited to specific products and batches and do not amount to a ban on Amoxicillin.
She urged members of the public to disregard the misleading video and rely only on information from NAFDAC’s official platforms.
The Director-General reaffirmed the agency’s commitment to protecting public health through transparent, science-based regulatory oversight.
NAN.
About the Author
